Thrivent Financial for Lutherans Has $9.46 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA

Thrivent Financial for Lutherans lessened its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 39.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 499,282 shares of the real estate investment trust’s stock after selling 331,241 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Sabra Healthcare REIT were worth $9,456,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Cornerstone Wealth Management LLC boosted its stake in shares of Sabra Healthcare REIT by 256.6% in the 3rd quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after purchasing an additional 28,625 shares during the last quarter. AlphaQuest LLC boosted its stake in shares of Sabra Healthcare REIT by 309.2% in the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock valued at $2,700,000 after purchasing an additional 109,444 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Sabra Healthcare REIT by 8.2% in the 3rd quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock valued at $51,962,000 after purchasing an additional 211,686 shares during the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Sabra Healthcare REIT by 9.9% in the 3rd quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after purchasing an additional 81,293 shares during the last quarter. Finally, Greenland Capital Management LP bought a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $4,194,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Shares of SBRA stock opened at $21.01 on Wednesday. The company’s fifty day simple moving average is $20.31 and its 200-day simple moving average is $19.58. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm has a market cap of $5.30 billion, a PE ratio of 33.35, a P/E/G ratio of 1.67 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a 12 month low of $17.08 and a 12 month high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm had revenue of $221.75 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the prior year, the firm posted $0.37 earnings per share. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Shareholders of record on Friday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.7%. The ex-dividend date is Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Analysts Set New Price Targets

Several analysts recently commented on SBRA shares. Truist Financial raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. Citigroup raised their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Citizens Jmp raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research note on Wednesday, February 18th. Scotiabank raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd. Finally, UBS Group raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 13th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.20.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.